E. D. Vries

发表

Differential Expression of Thymus and Activation Regulated Chemokine and Its Receptor CCR4 in Nodal and Cutaneous Anaplastic Large-Cell Lymphomas and Hodgkin's Disease

C. Meijer, E. Bloemena, R. Willemze, 2002, Modern Pathology.

University of Groningen Indomethacin induces apoptosis via a MRPI-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRPI

S. Jong, M. Deen, A. Regeling, 2007 .

A phase I dose escalating study of the angiogenesis inhibitor thrombospondin-1 mimetic (ABT-510) in patients with advanced cancer

J. Verweij, R. Hoekstra, R. Humerickhouse, 2002 .

Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)

S. Willemsen, S. Kittanakom, M. Nelle, 2017, The Lancet.

Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase 1 study in patients with advanced solid malignancies

S. Sleijfer, J. Verweij, W. Loos, 2006 .

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy

A. V. D. Van Der Zee, E. D. de Vries, P. Willemse, 2002, British Journal of Cancer.

Skin cancer incidence and survival in European children and adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project.

E. Steliarova-Foucher, A. Eggermont, E. de Vries, 2006, European journal of cancer.

Patients' perception of the cause of their melanoma differs from that of epidemiologists

A. Eggermont, A. Eggermont, P. Autier, 2002, The British journal of dermatology.

Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site.

M. Janssen-Heijnen, E. Bastiaannet, T. Nijsten, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Assessing physicians’ preferences on skin cancer treatment in Europe

C. Proby, M. Ulrich, E. Stockfleth, 2012, The British journal of dermatology.

Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010–2050

E. Stockfleth, M. Trakatelli, J. Coebergh, 2012, The British journal of dermatology.

Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.

H. Karim-Kos, T. Nijsten, E. de Vries, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in the Netherlands

T. Nijsten, C. Looman, E. de Vries, 2009, The British journal of dermatology.

Risks of different skin tumor combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population based cohorts: 1989 - 2009.

T. Nijsten, E. de Vries, L. Hollestein, 2016, Dermatology online journal.

Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001.

I. Soerjomataram, V. Lemmens, E. de Vries, 2005, European journal of cancer.

Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands.

M. Janssen-Heijnen, S. Houterman, A. Eggermont, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.